WuXi Biologics, a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing.

Biotechnology

WuXi Biologics

Zhisheng Chen

Weichang Zhou

Lina Fan

Sherry Gu

Kai Shen

Ing Hou Loh

Yun Hu

Juergen Hinderer

Brendan McGrath

Shiwen Lin

Keqiang Shen

Weijun (Wesley) Wang

Xuejun (Sherry) Gu

Li Xiong

Ming Tu

Cong Ding

William Aitchison

JiJie Gu

Chiang Syin

Jing Li

Michelle M Chen

Angus Turner

The leadership team at WuXi Biologics has a history of experience in the pharmaceutical and biotechnology industries. The team has worked as counsel at Baker Donelson, as an attorney at Stites & Harbison, PLLC, and as an attorney at Harris Shelton Hanover Walsh, PLLC. The team also has experience as a pharmaceutical sciences senior research technologist at St. Jude Children's Research Hospital, an associate director at Ipsen/Baxalta/Shire, and a scientist at Shire HGT. Additionally, the team has experience as an investigator at GSK and as an instructor at Dana-Farber Cancer Institute.

Leadership Team

CEO and Executive Team

Leadership Team

About

Team members

Other teams at WuXi Biologics

CEO and Executive Team